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What is Hepatitis B? 
• DNA virus spread through 
transmission of bodily fluids
• Causes a wide spectrum of liver 
disease
• 5-10% of infected adults develop 
chronic infection 
• 20-30% of Chronic infections lead to 
cirrhosis or hepatocellular 
carcinoma
• ~300 million HBV carriers 
worldwide 
• 686,000 deaths annually
-Liang et al 2009
HBsAg and HBeAg
• Surface antigen:
• Major surface protein
• Chronic HBV infection: presence of 
hepatitis B surface antigen (HBsAg) for 
>6 months
• key diagnostic marker
• E antigen
• Indicated viral replication and infectivity
-Amini et al, 2017
-Nguyen et al, 2008
-Milich D and Liang T, 2003
Transgenic Mouse Model Used by the IAR
• Genome of C57BL genetically engineered to 
produce hepatitis B 
• Liver and kidney tissue produce complete viral 
particle with associated DNA, HBsAg, HBeAg, 
HBcAg 
• No associated cytopathology 
-Guidotti et al, 1995
What We Know
• Weak observed correlation between HBeAg levels and expressed viral 
DNA 
• No record of correlation between HBsAg levels and expressed viral 
DNA 
• Data suggest that HBsAg levels decrease over time in males
• No data regarding decrease in females
Purpose of experiment 
• Develop a timeline showing HBsAg levels over time in both males and 
females
• Determine correlation between HBsAg levels and expressed viral DNA 
• Confirm correlation between HBeAg levels and expressed viral DNA
Methods: Samples
• Serum collected from pups 
weekly from 4-10 weeks of age
• Mice were euthanized and 
livers were harvested at 10 
weeks
Methods: Antigen Analysis
• HBsAg-specific ELISA with 
calibrator of known WHO (IU/mL) 
units
• Absorbance was matched to 
standard curve to determine HBsAg 
levels from each collection date
• HBeAg-specific ELISA with 
calibrator of known PEI units
• Absorbance was matched to 
standard curve to determine HBsAg 
levels from each collection date
Methods: DNA Analysis 
• Serum DNA was extracted using 
QIAamp cador Pathogen Mini Kit 
• Liver DNA was extracted by 
phenol-chloroform extraction 
• Extracted DNA was analyzed by 
real-time qPCR
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HBV Serum DNA vs Liver DNA at Necropsy 




































L) No significant difference
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HBeAg vs Serum HBV DNA Linear Regression








































































































HBeAg vs Viral DNA
• HBeAg vs. Serum HBV DNA: 
Weak/moderate correlation
• HBeAg vs. Liver HBV DNA: Strong 
correlation
• HBeAg useful as surrogate 
marker for liver and serum HBV 
DNA 
Serum HBV DNA vs. Liver HBV DNA
• Strong positive correlation
• Serum HBV DNA useful as 
surrogate marker for liver HBV 
DNA 
HBsAg Levels
• Significantly decrease over 
time
• Implications:
• HBsAg commonly used as 
diagnostic marker
• Potential erroneous results 
in mouse studies 
• Not a reliable indicator of 
liver HBV DNA levels 
Conclusion
• Serum HBV DNA levels 
remain constant overtime, 
suggesting constant liver HBV 
DNA over time 
• HBsAg levels significantly 
decrease over time. Why?
Hypothesis 
• HBsAg-specific immunoglobulins 
begin to be produced by the 
mice
• HBsAg is neutralized and degraded 
by phagocytosis 
• Suggests possible autoimmune 
response
Further research
• Repeat experiment with larger sample size
• Support evidence that HBsAg levels significantly decrease in male mice
• Clarify non-significant decrease in female mice 
• Perform IgG-specific ELISA alongside HBsAg-specific ELISA
• Analyze suspected inverse relationship between IgG and HBsAg levels
Works Cited
1. Liang, T. J. Hepatitis B: The Virus and Disease. Hepatol. Baltim. Md 2009, 
49 (5 Suppl), S13-21.
2. Amini, A.; Varsaneux, O.; Kelly, H.; Tang, W.; Chen, W.; Boeras, D. I.; 
Falconer, J.; Tucker, J. D.; Chou, R.; Ishizaki, A.; et al. Diagnostic Accuracy 
of Tests to Detect Hepatitis B Surface Antigen: A Systematic Review of the 
Literature and Meta-Analysis. BMC Infect. Dis. 2017, 17 (Suppl 1).
3. Nguyen, D. H.; Ludgate, L.; Hu, J. Hepatitis B Virus-Cell Interactions and 
Pathogenesis. J. Cell. Physiol. 2008, 216 (2), 289–294.
4. Milich, D.; Liang, T. J. Exploring the Biological Basis of Hepatitis B e 
Antigen in Hepatitis B Virus Infection. Hepatology 2003, 38 (5), 1075–
1086.
5. Guidotti, L. G.; Matzke, B.; Schaller, H.; Chisari, F. V. High-Level Hepatitis B 
Virus Replication in Transgenic Mice. J. Virol. 1995, 69 (10), 6158–6169.
Thank You!
